Pharmafile Logo
Pharmafocus logo
Advanced Search

health economics and outcomes research

Showing 3 posts of 3 posts found.

Redefining the value of medicines with patients at the centre

November 4, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, health economics and outcomes research, market access, pharma

Liz Lewis, Head of Global Oncology Patient Value, Policy and Access at Takeda Oncology, discusses the importance and challenges of …

Feature
222170359

Damage control: How will pharma manage the health economic impacts of Brexit?

October 23, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HEOR, brexit, health economics and outcomes research, pharma

When it comes to life sciences and patient outcomes, the UK’s destiny is inextricably tied to its relationship with the …

Feature
capture

The economics of mental health

October 8, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HEOR, health economics and outcomes research, mental health, pharma

Louis Goss examines mental health from a health economics and outcomes research (HEOR) perspective and asks what might be done …

Feature

Latest content

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024

PeptiDream and Novartis extend peptide discovery collaboration

April 30, 2024

Pfizer’s Beqvez approved by FDA for haemophilia B treatment

April 29, 2024